ClinicalTrials.Veeva

Menu

Innate Immunity in Allergic Asthma

University of Central Florida logo

University of Central Florida

Status

Enrolling

Conditions

Asthma

Study type

Observational

Funder types

Other

Identifiers

NCT06068335
CR00001150

Details and patient eligibility

About

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants must be at least 18 years of age
  • no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

Exclusion criteria

  • Pregnant women and prisoners will be excluded from the study.
  • Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.

Trial contacts and locations

1

Loading...

Central trial contact

Erica Martin, B.S.; Amoy Fraser, PhD, CCRP, PMP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems